Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
7,480.00
-160.00 (-2.09%)
Apr 30, 2026, 3:30 PM KST
-25.65% (1Y)
| Market Cap | 173.96B -8.7% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 146,985 |
| Average Volume | 101,449 |
| Open | 7,640.00 |
| Previous Close | 7,640.00 |
| Day's Range | 7,470.00 - 7,640.00 |
| 52-Week Range | 7,340.00 - 11,520.00 |
| Beta | 0.90 |
| RSI | 38.06 |
| Earnings Date | Nov 11, 2025 |